Cancer (Oncology)

Oncology drug approvals rise, with help from China

Checkpoint Inhibitors: A decade of innovation

ESMO 2021: Oncology developers present their findings

Live biotherapeutics change the pharma landscape

ASCO 2021- Oncology developers disclose their latest data

Oncology approvals rise, driven by novel compounds

Hot targets in immuno-oncology

The Bispecific Approach, Interviews with Merus, Genmab and NovalGen

Why we should take a second look at RNA therapeutics

Technology Transfer: Partnering with the US National Cancer Institute